Jump to navigation Jump to search
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
ATC code
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass249.29 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Sulfapyridine


Most recent articles on Sulfapyridine

Most cited articles on Sulfapyridine

Review articles on Sulfapyridine

Articles on Sulfapyridine in N Eng J Med, Lancet, BMJ


Powerpoint slides on Sulfapyridine

Images of Sulfapyridine

Photos of Sulfapyridine

Podcasts & MP3s on Sulfapyridine

Videos on Sulfapyridine

Evidence Based Medicine

Cochrane Collaboration on Sulfapyridine

Bandolier on Sulfapyridine

TRIP on Sulfapyridine

Clinical Trials

Ongoing Trials on Sulfapyridine at Clinical

Trial results on Sulfapyridine

Clinical Trials on Sulfapyridine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Sulfapyridine

NICE Guidance on Sulfapyridine


FDA on Sulfapyridine

CDC on Sulfapyridine


Books on Sulfapyridine


Sulfapyridine in the news

Be alerted to news on Sulfapyridine

News trends on Sulfapyridine


Blogs on Sulfapyridine


Definitions of Sulfapyridine

Patient Resources / Community

Patient resources on Sulfapyridine

Discussion groups on Sulfapyridine

Patient Handouts on Sulfapyridine

Directions to Hospitals Treating Sulfapyridine

Risk calculators and risk factors for Sulfapyridine

Healthcare Provider Resources

Symptoms of Sulfapyridine

Causes & Risk Factors for Sulfapyridine

Diagnostic studies for Sulfapyridine

Treatment of Sulfapyridine

Continuing Medical Education (CME)

CME Programs on Sulfapyridine


Sulfapyridine en Espanol

Sulfapyridine en Francais


Sulfapyridine in the Marketplace

Patents on Sulfapyridine

Experimental / Informatics

List of terms related to Sulfapyridine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Sulfapyridine, original UK spelling sulphapyridine, is a sulfonamide antibacterial. At one time it was commonly referred to as M&B.

Sulfapyridine is no longer prescribed for treatment of infections in humans. However, it may be used to treat linear IgA disease. It is a good antibacterial drug, but its water solubility is very pH dependent. Thus there is a risk of crystallization within the bladder or urethra, which could lead to pain or blockage. As with other sulfonamides, there is a significant risk of agranulocytosis, and this, rather than the development of resistance by bacteria, is the main reason for its decline in use.

It was discovered by Lionel Whitby at the British firm May & Baker Ltd and logged in their Test Book on 2 November, 1937 under Code No M&B 693.[1] It was successfully used to treat Winston Churchill's bacterial pneumonia in 1942. In a subsequent radio broadcast he said: "This admirable M&B from which I did not suffer any inconvenience, was used at the earliest moment and, after a week's fever, the intruders were repulsed." In 1944 M&B 693 also saved Nero, the Royal Circus lion, from pneumonia. [Glasgow Evening News January 1944.]

The drug sulfasalazine is structurally one molecule of mesalamine linked to one molecule of sulfapyridine with an azo bond.

M&B 693 was one of the first generation of sulphonamide antibiotics. It has been reported as the first chemical cure for pneumonia. It could either be taken in tablet form or the powder could be placed in wounds. It was used so widely during the Second World War that May & Baker had difficulty keeping up with demand. It was later largely superseded by penicillin and other sulfonamides.



  1. Lesch, John (2007). "Chapter 7". The First Miracle Drugs (illustrated ed.). Oxford University Press. ISBN 0-19-518775-X. |access-date= requires |url= (help)

Template:Sulfonamides and trimethoprim